Search Results - "Remijn, J.A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department

    Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department by Nijhuis, R.H.T., Russcher, A., de Jong, G.J., Jong, E., Herder, G.J.M., Remijn, J.A., Verweij, S.P.

    Published in Journal of clinical virology (01-12-2020)
    “…•The prevalence of SARS-CoV-2 in blood from patients with COVID-19 was determined.•SARS-CoV-2 was found in 5.9 % of the tested patients.•Plasma should not be…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Citalopram is a more potent platelet function inhibitor than paroxetine in a case–control study

    Citalopram is a more potent platelet function inhibitor than paroxetine in a case–control study by VAN HOLTEN, T. C., ROEST, M., RIPHAGEN, J., JANSEN, C., NAARDING, P., ADRIAANSEN, H. J., DE GROOT, P. G., REMIJN, J. A.

    Published in Journal of thrombosis and haemostasis (01-06-2012)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Role of the fibrinogen γ‐chain sequence γ316–322 in platelet‐mediated clot retraction

    Role of the fibrinogen γ‐chain sequence γ316–322 in platelet‐mediated clot retraction by Remijn, J. A., IJsseldijk, M. J. W., De Groot, P. G.

    Published in Journal of thrombosis and haemostasis (01-10-2003)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: